Zydus Lifesciences Ltd Share Price History
₹ 3.9 Cr
Volume transacted
38.7 K
stocks traded
Last Updated time: 04 Nov 9.00 AM
Zydus Lifesciences Ltd
BSE
01 Nov, 2024
10042.2 (0.2%)
Prev Close
1001.85
Open Price
1002.05
Bid Price (QTY)
0.0 (0)
Offer Price (QTY)
0.0 (0)
Volume
12110
Today's High / Low
1014.3 / 999.0
52 WK High / Low
1323.9 / 570.3
NSE
01 Nov, 2024
10042.8 (0.3%)
Prev Close
1001.25
Open Price
1009.25
Bid Price (QTY)
1004.0 (100)
Offer Price (QTY)
0.0 (0)
Volume
732810
Today's High / Low
1013.9 / 998.5
52 WK High / Low
1324.3 / 570.3
PRICE
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
Market price Over Time
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | Price | Day Open | Day High | Day Low |
|---|
| 01 Nov 2024 | 1004 | 1002.05 | 1014.3 | 998.95 |
| 31 Oct 2024 | 1001.85 | 985 | 1003.75 | 985 |
| 30 Oct 2024 | 985.55 | 1007.4 | 1007.4 | 982.8 |
| 29 Oct 2024 | 1002.3 | 1020 | 1020 | 988.3 |
| 28 Oct 2024 | 1006.65 | 993.5 | 1016.25 | 977.2 |
| 25 Oct 2024 | 990.2 | 1013.95 | 1013.95 | 986.45 |
| 24 Oct 2024 | 1005.1 | 1010.55 | 1010.55 | 997.9 |
| 23 Oct 2024 | 1000.5 | 981.05 | 1016.35 | 981.05 |
| 22 Oct 2024 | 988.2 | 1024.95 | 1024.95 | 984.2 |
| 21 Oct 2024 | 1005.2 | 1020 | 1028.7 | 1002.3 |
| Date |  Price |
|---|---|
| 01 Nov 2024 | 1004 |
| 31 Oct 2024 | 1001.85 |
| 30 Oct 2024 | 985.55 |
| 29 Oct 2024 | 1002.3 |
| 28 Oct 2024 | 1006.65 |
| 25 Oct 2024 | 990.2 |
| 24 Oct 2024 | 1005.1 |
| 23 Oct 2024 | 1000.5 |
| 22 Oct 2024 | 988.2 |
| 21 Oct 2024 | 1005.2 |
Returns Comparison Table
| Entity | 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|
| Cipla Ltd | 4.7 | -6.3 | 0.8 | 9.8 | 29.8 | 71.5 | 232.4 | 135.2 |
| Torrent Pharmaceuticals Ltd | -6.7 | -4.8 | -0.2 | 20.0 | 67.3 | 122.9 | 256.2 | 604.7 |
| Sun Pharmaceuticals Industries Ltd | -0.1 | -3.2 | 8.3 | 22.4 | 66.5 | 129.0 | 324.8 | 118.2 |
| Zydus Lifesciences Ltd | 1.4 | -7.1 | -19.1 | 1.6 | 74.5 | 100.4 | 293.3 | 261.4 |
| Divis Laboratories Ltd | 2.2 | 8.8 | 19.9 | 48.9 | 76.4 | 12.8 | 238.9 | 553.9 |
| Mankind Pharma Ltd | 9.5 | 4.4 | 34.2 | 15.3 | 54.2 | 0.0 | 0.0 | 0.0 |
| Entity | 1W |
|---|---|
| Cipla Ltd | 4.7 |
| Torrent Pharmaceuticals Ltd | -6.7 |
| Sun Pharmaceuticals Industries Ltd | -0.1 |
| Zydus Lifesciences Ltd | 1.4 |
| Divis Laboratories Ltd | 2.2 |
| Mankind Pharma Ltd | 9.5 |
Last updated time: 04 Nov 9.00 AM
Growth Parameters
| Parameter | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|
| Sales | 9572 | 11954 | 13166 | 14253 | 14404 | 15110 | 17237 | 19547 |
| Sales YoY Gr. | - | 24.9% | 10.1% | 8.3% | 1.1% | 4.9% | 14.1% | 13.4% |
| Adj EPS | 14.48 | 17.07 | 18.08 | 11.48 | 20.87 | 44.65 | 19.74 | 38.31 |
| YoY Gr. | - | 17.9% | 5.9% | -36.5% | 81.8% | 113.9% | -55.8% | 94.1% |
| Adj Net Profit | 1483 | 1748 | 1852 | 1176 | 2138 | 4572 | 1997 | 3854 |
| BVPS | 67.97 | 85.4 | 101.43 | 101.33 | 126.88 | 166.01 | 173.08 | 197.11 |
| Parameter | 2017 |
|---|---|
| Sales | 9572 |
| Sales YoY Gr. | - |
| Adj EPS | 14.48 |
| YoY Gr. | - |
| Adj Net Profit | 1483 |
| BVPS | 67.97 |
Key Financial Parameters
| Parameter | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|
| Return on Capital Emp. % | 22.75 | 28.06 | 16.02 | 17.97 | 15.65 | 11.91 | 15.12 | 14.43 | 16.25 | 23.94 |
| Op. Profit Mgn % | 20.43 | 25.41 | 21.2 | 24.61 | 24.11 | 20.43 | 23.86 | 23.61 | 23.35 | 29.04 |
| Net Profit Mgn % | 13.46 | 19.98 | 15.49 | 14.62 | 14.07 | 10.33 | 16.48 | 29.6 | 14.07 | 19.72 |
| Debt to Equity % | 0.7 | 0.51 | 0.6 | 0.68 | 0.7 | 0.77 | 0.54 | 0.29 | 0.16 | 0.05 |
| Parameter | 2015 |
|---|---|
| Return on Capital Emp. % | 22.75 |
| Op. Profit Mgn % | 20.43 |
| Net Profit Mgn % | 13.46 |
| Debt to Equity % | 0.7 |
Check out other companies share price history
Sun Pharmaceuticals Industries Ltd
Sun Pharmaceutical Industries Limited including its subsidiaries and associates ...
Divis Laboratories Ltd
Divi's Laboratories Ltd. is one of the leading pharmaceutical companies in the w...
Cipla Ltd
The Company is in the business of manufacturing, developing, and marketing wide ...
Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Limited, the flagship Company of the Torrent Group, is o...
Mankind Pharma Ltd
Mankind Pharma Ltd. was incorporated on July 3, 1991, as a Private Limited Compa...
FAQs for Zydus Lifesciences Ltd Share Price History
What are the key events that typically impact Zydus Lifesciences Ltd's share price history?
How do stock splits affect Zydus Lifesciences Ltd's share price history?
How do dividends impact the share price history of Zydus Lifesciences Ltd?
How do corporate announcements affect Zydus Lifesciences Ltd’s share price history?
How can I use technical analysis to understand Zydus Lifesciences Ltd’s share price history?
Unlimited trading at just
Rs. 199*